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VAMP/synaptobrevin as an acrosomal
marker for human sperm
Joa˜o Ramalho-Santos, Ph.D.,a Yukihiro Terada, M.D., Ph.D.,b and
Gerald Schatten, Ph.D.c
Division of Reproductive Sciences, Oregon Regional Primate Research Center, Oregon Health Sciences
University, Beaverton, Oregon
Objective: To determine the possible use of the mammalian acrosomal marker vehicle-associated membrane
protein (VAMP)/synaptobrevin to detect acrosome abnormalities in human sperm.
Design: Analysis of human sperm after fixation and staining with an anti-VAMP antibody.
Setting: An academic research institution.
Patient(s): Semen samples from consenting patients who were participating in an infertility treatment
program.
Intervention(s): Human sperm samples were fixed, permeabilized with detergent, and examined by immu-
nocytochemistry.
Main outcome measure: Immunostaining.
Result(s): Observation of sperm from patients with no obvious sperm morphological defects revealed normal
looking acrosomes, as assessed by VAMP immunostaining. However, severe acrosome malformations were
detected in other cases. The observations registered varied from the absence of a fully formed organelle in
samples of patients with globozoospermia to abnormal VAMP staining in samples from patients with
acrosomal defects.
Conclusion: VAMP/synaptobrevin may be a useful marker for the functional assessment of acrosomal status
in human sperm. (Fertil Steril 2002;77:159–61. ©2002 by American Society for Reproductive Medicine.)
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The acrosome is a large secretory vesicle
localized on the heads of a spermatozoa in
most species. Fusion between the acrosome
membrane and the sperm plasma membrane
(i.e., the acrosome reaction) results in the re-
lease of acrosomal contents, thus priming the
sperm for egg interactions. Although many as-
pects related to the triggering of the acrosome
reaction have been characterized, little is
known on what modulates membrane merging
itself.
One protein that has been recently identified
on the human acrosome is the vesicle-associ-
ated membrane protein (VAMP), also known
as synaptobrevin (1). Together with other ac-
rosomal components, VAMP may have an im-
portant functional role in promoting membrane
fusion during the acrosome reaction (1).
We have previously used VAMP staining to
detect the acrosome after intracytoplasmic
sperm injection (ICSI), a technique used to
overcome certain types of male factor infertil-
ity and that allows for the direct injection of a
spermatozoon into an oocyte (2). Using the
rhesus monkey as a model system, we have
shown that a VAMP “collar” (probably corre-
sponding to the acrosome equatorial segment)
sharply separates the decondensed (posterior)
portion of the sperm head from the apical part,
which remains largely condensed (2).
In this study, we have attempted to use
VAMP to detect acrosome abnormalities in
semen samples from patients who were partic-
ipating in an infertility treatment program. Al-
though the original clinical diagnosis varied,
infertility in all samples was diagnosed as male
factor using a recently described assay (3).
MATERIALS AND METHODS
Semen samples were obtained from con-
senting infertility patients treated at the Tohoku
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University Hospital (3). All samples were collected and
frozen at the Tohoku University Hospital, Japan. All samples
were collected and frozen at the Tohoku University Hospital
before analysis at the Oregon Health Sciences University.
We were unable to analyze fresh samples during the course
of this work and therefore cannot assess the possible effects
of freezing on VAMP staining.
Samples were used in accordance with the guidelines
approved by the Institutional Review Boards (IRBs) of both
Tohoku University and Oregon Health Sciences University.
Appropriate IRB approval was obtained in both institutions.
Frozen samples were thawed in warm modified Tyrode-
lactate medium with pyruvate and albumin, and immunocy-
tochemistry using VAMP antibodies (a kind gift of Dr. Gary
Wessel, Brown University; and obtained commercially via
Synaptic Systems, Go¨ttingen, Germany) was carried out as
described in detail elsewhere (1). Briefly, poly-L-lysine
coated coverslips with attached sperm were fixed in 2%
formaldehyde, permeabilized in 1% Triton X-100, and
blocked by further incubation in phosphate-buffered saline
(PBS) containing 2 mg/ml bovine serum albumin and 100
mM glycine. For labeling, anti-VAMP antibody was solubi-
lized in the blocking solution (1:100 dilution) and incubated
with the coverslips for 1–2 h at room temperature. After
washing in PBS containing 0.1% Triton X-100, the samples
were sequentially labeled with TRITC-conjugated appropri-
ate secondary antibodies (Zymed, San Francisco, CA) and
the DNA stain 4-6-diamino-2-phenylindole (Molecular
Probes, Eugene, OR). The coverslips were then mounted in
VectaShield mounting medium (Vector Labs, Burlingame,
CA) and sealed with nail polish. Samples were examined
with a Zeiss Axiophot epifluorescence-equipped microscope.
RESULTS
Sperm samples from six patients were used in this study
(Table 1). Although the original clinical diagnosis varied
(Table 1), infertility in all samples was tentatively diagnosed
as male factor using the recently described sperm-ubiquitin
tag immunoassay (3).
In Patients 1 and 2 (Table 1), there were no obvious
sperm morphological abnormalities (Fig. 1A, A’), and the
predominant defect consisted of cells in the ejaculate as well
as low motility in Patient 1 (Table 1). As expected, VAMP
staining in these samples was identical to what had already
been described in human sperm of proven fertility (1), with
a strong label on the sperm head, prominent on the acrosome
equatorial segment (Fig. 1A, arrows). Although some label
was also found in the sperm tail, this staining is likely to be
unspecific, since a similar pattern could also be obtained in
control experiments, using only the fluorescent secondary
antibodies, in the absence of any VAMP probe (data not
shown).
Samples from patients 3 and 4 showed head and tail
sperm defects, as well as low motility (Table 1). VAMP
staining was frequently abnormal in these samples (Fig. 1B,
B’). The most frequent departures from the norm, as as-
sessed by VAMP staining, consisted of acrosomes that were
not fully developed (Fig. 1B, arrows), as well as label in the
neck/midpiece region of the sperm (Fig. 1B, arrowheads).
These findings are most likely due to problems in acrosome
formation during spermiogenesis and/or to abnormal pro-
cessing of the residual cytoplasmic droplet. Some defects in
sperm head condensation were also present (Fig. 1B’, ar-
row).
In sperm of two patients with globozoospermia (patients
5 and 6, Table 1), VAMP staining was even more striking
(Fig. 1C, C’). As noted previously (3), the sperm DNA is not
fully condensed in these patients (Fig. 1C’). Sperm count
and motility were low in patient 5 (Table 1), and sperm from
patient 6 had large heads (Fig. 1C’). Furthermore, VAMP
staining was only vestigial (Fig. 1C, arrows), which suggests
that the acrosome had not fully formed. Indeed, the results
obtained were reminiscent of what has been described re-
T A B L E 1
Sperm parameters of patients with male factor infertility analyzed for VAMP acrosomal staining.
Patient
Sperm count
(106 sperm/mL)
Sperm motility
(%)
Predominant
defect
Original clinical
diagnosis
1 256.0 25.0 Cells in ejaculate Male factor
2 70.0 54.2 Cells in ejaculate Tubal
3 216.0 47.0 Lasso tails Idiopathic
Twin tails/heads
4 213.0 33.0 Lasso tails Tubal and
Twin tails male factor
5 18.3 20.0 Globozoospermia Idiopathic
6 184.0 73.6 Globozoospermia Male factor
Note: Patients 1–6 correspond to patients 6, 9, 13, 16, 1, and 17 discussed in Sutovsky et al. (3), respectively.
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garding the presence of VAMP in the developing acrosome
of round spermatids (4).
DISCUSSION
The status and content of the human acrosome may be
evaluated using several well-established techniques. In this
study, we have used VAMP/synaptobrevin as a potential
functional marker for the acrosome in the sperm of men
participating in an infertility treatment program.
In some samples the acrosome seemed normal and poor
sperm function could not be ascribed to organelle malfor-
mation or lack of membrane fusion modulators active during
the acrosome reaction, such as VAMP. Clinically relevant
parameters affected in these cases included low sperm mo-
tility or presence of cells in the ejaculate. However, in other
instances there seemed to be some correlation between lower
fertility and acrosome malformations as detected by VAMP
staining. This was most evident in samples of patients with
globozoospermia, where the acrosome was mostly vestigial,
with similarities to the immature organelle found in round
spermatids (4).
Since VAMP is involved in membrane fusion during the
acrosome reaction (1), its presence, misplacement, or ab-
sence in the human acrosome may offer some indication as
to the fertilization potential of human sperm.
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F I G U R E 1
VAMP in human sperm. (A), Normal VAMP staining in human
sperm, with a concentration on the sperm head and the
acrosome equatorial segment (arrows). Corresponding DNA
image shown in A’. (B), Sperm with abnormal VAMP staining,
which suggests misformed acrosomes (arrows), and abnor-
mal presence of VAMP in the sperm midpiece (arrowheads).
The DNA image (B’) revealed misshapen heads in some
cases (arrow). (C), Sperm from patients with globozoosper-
mia, showing vestigial VAMP staining on the sperm head
(arrows). For clarity, traces of the DNA staining (shown in C’)
have been superimposed on the VAMP image. Sperm from
patient 5 is noted by an asterisk in C’. The bar represents 5
m.
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